244 related articles for article (PubMed ID: 31519682)
1. Patient and provider factors associated with enrolment in the pre-end-stage renal disease pay-for-performance programme in Taiwan: a cross-sectional study.
Hu HY; Jian FX; Lai YJ; Yen YF; Huang N; Hwang SJ
BMJ Open; 2019 Sep; 9(9):e031354. PubMed ID: 31519682
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of a pre-ESRD pay-for-performance programme in advanced chronic kidney disease patients.
Hsieh HM; Lin MY; Chiu YW; Wu PH; Cheng LJ; Jian FS; Hsu CC; Hwang SJ
Nephrol Dial Transplant; 2017 Jul; 32(7):1184-1194. PubMed ID: 28486670
[TBL] [Abstract][Full Text] [Related]
3. Effect of national pre-ESRD care program on expenditures and mortality in incident dialysis patients: A population-based study.
Lin MY; Cheng LJ; Chiu YW; Hsieh HM; Wu PH; Lin YT; Wang SL; Jian FX; Hsu CC; Yang SA; Lee HL; Hwang SJ
PLoS One; 2018; 13(6):e0198387. PubMed ID: 29856821
[TBL] [Abstract][Full Text] [Related]
4. Pay-for-performance programmes reduce stroke risks in patients with type 2 diabetes: a national cohort study.
Chou CW; Kung PT; Chou WY; Tsai WC
BMJ Open; 2019 Oct; 9(10):e026626. PubMed ID: 31619415
[TBL] [Abstract][Full Text] [Related]
5. Effect of a Pay-for-Performance Program on Renal Outcomes Among Patients With Early-Stage Chronic Kidney Disease in Taiwan.
Lin MT; Hsu CN; Lee CT; Cheng SH
Int J Health Policy Manag; 2022 Aug; 11(8):1307-1315. PubMed ID: 33906336
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary care program in pre-end-stage kidney disease from 2010 to 2018 in Taiwan.
Lin MY; Chang MY; Wu PY; Wu PH; Lin MH; Hsu CC; Chang JM; Hwang SJ; Chiu YW
J Formos Med Assoc; 2022 Feb; 121 Suppl 1():S64-S72. PubMed ID: 34980548
[TBL] [Abstract][Full Text] [Related]
7. Association of pre-ESRD care education with patient outcomes in a 10-year longitudinal study of patients with CKD stages 3-5 in Taiwan.
Chou CL; Chung CH; Chiu HW; Liao CT; Wu CC; Hsu YH; Chien WC
Sci Rep; 2021 Nov; 11(1):22602. PubMed ID: 34799610
[TBL] [Abstract][Full Text] [Related]
8. Does the pay-for-performance programme reduce the emergency department visits for hypoglycaemia in type 2 diabetic patients?
Yu HC; Tsai WC; Kung PT
Health Policy Plan; 2014 Sep; 29(6):732-41. PubMed ID: 23894069
[TBL] [Abstract][Full Text] [Related]
9. Does enhanced diabetes management reduce the risk and improve the outcome of tuberculosis?
Lo HY; Yang SL; Lin HH; Bai KJ; Lee JJ; Lee TI; Chiang CY
Int J Tuberc Lung Dis; 2016 Mar; 20(3):376-82. PubMed ID: 27046720
[TBL] [Abstract][Full Text] [Related]
10. Does pay-for-performance benefit patients with multiple chronic conditions? Evidence from a universal coverage health care system.
Chen CC; Cheng SH
Health Policy Plan; 2016 Feb; 31(1):83-90. PubMed ID: 25944704
[TBL] [Abstract][Full Text] [Related]
11. The effects of pay-for-performance on tuberculosis treatment in Taiwan.
Li YH; Tsai WC; Khan M; Yang WT; Lee TF; Wu YC; Kung PT
Health Policy Plan; 2010 Jul; 25(4):334-41. PubMed ID: 20207703
[TBL] [Abstract][Full Text] [Related]
12. The unintended consequence of diabetes mellitus pay-for-performance (P4P) program in Taiwan: are patients with more comorbidities or more severe conditions likely to be excluded from the P4P program?
Chen TT; Chung KP; Lin IC; Lai MS
Health Serv Res; 2011 Feb; 46(1 Pt 1):47-60. PubMed ID: 20880044
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan.
Cheng SL; Li YR; Huang N; Yu CJ; Wang HC; Lin MC; Chiu KC; Hsu WH; Chen CZ; Sheu CC; Perng DW; Lin SH; Yang TM; Lin CB; Kor CT; Lin CH
Int J Chron Obstruct Pulmon Dis; 2021; 16():2869-2881. PubMed ID: 34703221
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan.
Shen CH; Zheng CM; Kiu KT; Chen HA; Wu CC; Lu KC; Hsu YH; Lin YF; Wang YH
Medicine (Baltimore); 2016 Jun; 95(25):e3933. PubMed ID: 27336884
[TBL] [Abstract][Full Text] [Related]
15. Effects of Changes in Diabetes Pay-for-Performance Incentive Designs on Patient Risk Selection.
Hsieh HM; Tsai SL; Mau LW; Chiu HC
Health Serv Res; 2016 Apr; 51(2):667-86. PubMed ID: 26152649
[TBL] [Abstract][Full Text] [Related]
16. The association between participation in a pay-for-performance program and macrovascular complications in patients with type 2 diabetes in Taiwan: A nationwide population-based cohort study.
Hsieh HM; Lin TH; Lee IC; Huang CJ; Shin SJ; Chiu HC
Prev Med; 2016 Apr; 85():53-59. PubMed ID: 26740347
[TBL] [Abstract][Full Text] [Related]
17. Predicting mortality of incident dialysis patients in Taiwan--a longitudinal population-based study.
Wu PH; Lin YT; Lee TC; Lin MY; Kuo MC; Chiu YW; Hwang SJ; Chen HC
PLoS One; 2013; 8(4):e61930. PubMed ID: 23626754
[TBL] [Abstract][Full Text] [Related]
18. Factors related to continuing care and interruption of P4P program participation in patients with diabetes.
Yen SM; Kung PT; Sheen YJ; Chiu LT; Xu XC; Tsai WC
Am J Manag Care; 2016 Jan; 22(1):e18-30. PubMed ID: 26799201
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Sociodemographic Predictors of Mortality in End-Stage Renal Disease Inpatients in Rural Areas of the USA: Evidence From the Nationwide Inpatient Sample.
Adeyemi E; Okpe A; Enete C; Dixon K
Cureus; 2022 Jun; 14(6):e25624. PubMed ID: 35784967
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with end-stage renal disease (ESRD) in patients with atherosclerotic renal artery stenosis: a nationwide population-based analysis.
Yu TM; Sun CS; Lin CL; Wang CY; Chang PY; Chou CY; Chuang YW; Lee BJ; Kao CH
Medicine (Baltimore); 2015 May; 94(21):e912. PubMed ID: 26020404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
